Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 08, 2020

SELL
$4.0 - $21.53 $854,500 - $4.6 Million
-213,625 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$13.94 - $24.12 $1.78 Million - $3.09 Million
127,975 Added 149.42%
213,625 $4.58 Million
Q3 2019

Nov 05, 2019

BUY
$13.89 - $23.16 $425,728 - $709,854
30,650 Added 55.73%
85,650 $1.3 Million
Q2 2019

Aug 06, 2019

BUY
$16.27 - $20.51 $406,750 - $512,750
25,000 Added 83.33%
55,000 $1.07 Million
Q1 2019

May 08, 2019

BUY
$12.61 - $22.33 $378,300 - $669,900
30,000 New
30,000 $623,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $238M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Biondo Investment Advisors, LLC Portfolio

Follow Biondo Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biondo Investment Advisors, LLC with notifications on news.